Dave Morris, PhD

Vice President, Therapeutic Discovery

Dave leads the Therapeutic Discovery group at Precision BioSciences which is focused on the pharmacological profiling of ARCUS nucleases. He joined Precision from the UNC Eshelman School of Pharmacy and prior to UNC, GlaxoSmithKline. Dave has broad experience using analytical, cellular and molecular tools to understand the functional consequences of genetic mutations. He has an extensive background in cell and molecular biology, drug discovery and pharma-related technology development and implementation. When he is not at Precision, Dave can be found playing soccer or riding his bike.